Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
about
Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging conceptsPrognostic significance of volume-based PET parameters in cancer patients.Biomarkers and prognostic factors for mesotheliomaCorrelation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts.Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancerValue of (18)F-FDG PET/CT in the Detection of Ovarian MalignancyRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer.The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognosticationPrognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerImpact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.Correlation between Semi-Quantitative (18)F-FDG PET/CT Parameters and Ki-67 Expression in Small Cell Lung CancerLung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control studyDisease volumes as a marker for patient response in malignant pleural mesothelioma.Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study.Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.Correlation between histological grade and positron emission tomography parameters in cervical carcinoma.Prognostic value of metabolic tumor burden in lung cancer.Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.Novel molecular imaging in lung and pleural diseases.Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy.The role of PET/CT as a prognosticator and outcome predictor in lung cancer.Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.The age of reason for FDG PET image-derived indices.Volumetric assessment in malignant pleural mesothelioma.Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients.Clinical staging of malignant pleural mesothelioma: current perspectives.Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.Quantitative Metabolic Volumetric Product on 18Fluorine-2fluoro-2-deoxy-D-glucose-positron Emission Tomography/Computed Tomography in Assessing Treatment Response to Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Multiparametric AnalMetabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.
P2860
Q26863654-120A1550-46C3-4540-A297-537F98D196B0Q27687836-CF3E112E-54F2-470F-B548-ACF58F64A78BQ28387194-99C1EE5C-45E3-442A-B87E-AE8D6111B6C6Q30915309-45845F49-E6A8-4278-8128-BDAD012A3788Q33704511-42ACB0D1-9B8E-46F4-AD1A-6AC9E6EA5F2EQ33862523-5D6A2174-7BA4-488B-9CC8-A2F9FBAA6BBAQ34041728-4222377A-5E23-4F3F-8F7E-80825B407953Q34419020-65B4FF37-7CFE-4E7C-B9B3-6E184AF72CEFQ35162705-F0BA406A-BCEB-4ED6-9C60-39763A511497Q35200620-88E58BE1-C63E-49CF-B39E-508B7E6A3D15Q35274923-D7FE10F0-4E09-4B2E-895F-A13FB5933325Q35672382-F42AC13D-1A46-4BED-877C-6CF792E92088Q36032993-171CBD0C-F7F0-49C9-A165-6EB3FD287583Q36335078-B9E48FF5-AB94-4149-8330-B73C191B9C0CQ36461563-E8EFC002-09C0-492D-8D2E-7C13524F4A82Q36604990-DCD52505-0CD0-4D46-9706-7A9783937C5DQ36685687-BF72A29D-4D87-4F5E-8EFF-E91B2442952EQ36694617-EA71279F-AA41-416F-A176-FCD5D52F0528Q36702389-A1718FC5-5571-4C2D-8FA2-0EB0143F6360Q36769240-4CD0323A-597D-4E92-A300-F0D6DE2E2E41Q36918459-4FE2B149-7AAE-4A6D-826F-EF1F80DCE654Q37106866-2E075FA4-5D3D-4725-903B-C59D06C5EE3CQ37413672-8B278C6D-7B94-4B52-8068-D4113734E67EQ37696341-E845AC15-3DAF-4C4D-B8EE-CCC733A83F64Q37927164-5C04D4E3-1C92-4DC2-9EC1-F1F90F8C73D4Q38451242-5D7B73AB-14DF-46E5-9141-707984DE2A66Q38715401-51B083B8-E2F0-45E0-B78B-29AAC575825DQ38766127-B188CE0E-D3BE-415E-9B0D-94531F9FAA1AQ38843698-C1C598EF-190F-49E1-8EA7-AB62481AE133Q39065889-83C9A8E6-6A4E-45A1-A4CB-2B8D5B159076Q39434239-13106DF0-4412-4255-974A-1488070E4925Q40265325-8AFA5F6D-135B-4ADD-9EDE-4E2D6CAC220AQ40888969-5C030F58-0FD2-4CD3-953C-C8426502A97DQ40901350-1DB7D320-FD35-4975-9A96-47552326C415Q41522440-A8F76D99-6912-4B16-81A6-8A8DB8D4157AQ42360793-5A3A96E8-7E2D-4755-B060-F8EFB881B98AQ42373344-31554A3B-88BA-4616-AB5A-9E84BC672313Q42376463-0F227F7A-C001-4A83-AEB0-A26599652ADCQ43526833-57F3212E-55B3-4CAE-84F3-36B0D319DCE5Q43753631-8085ECF1-F9ED-42BE-85F2-03942A491922
P2860
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Volume-based parameter of 18)F ...... e and prognostic implications.
@en
Volume-based parameter of 18)F ...... e and prognostic implications.
@nl
type
label
Volume-based parameter of 18)F ...... e and prognostic implications.
@en
Volume-based parameter of 18)F ...... e and prognostic implications.
@nl
prefLabel
Volume-based parameter of 18)F ...... e and prognostic implications.
@en
Volume-based parameter of 18)F ...... e and prognostic implications.
@nl
P2093
P1476
Volume-based parameter of 18)F ...... e and prognostic implications.
@en
P2093
Byung-Tae Kim
Ho Yun Lee
Jhingook Kim
Kyung Soo Lee
Myung Jin Chung
Myung-Ju Ahn
Seung Hyup Hyun
Tae Sung Kim
Young Mog Shim
P2888
P304
P356
10.1245/S10434-010-1107-Z
P577
2010-05-12T00:00:00Z
P5875
P6179
1007093307